GS
GILD icon

Girard Securities’s Gilead Sciences GILD Stock Holding History

Girard Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,025
Closed -$356K – 140
2017
Q2 		$356K Sell
5,025
-317
-6% -$21.1K 0.27% 94
2017
Q1 		$363K Sell
5,342
-610
-10% -$42.9K 0.31% 89
2016
Q4 		$426K Buy
5,952
+197
+3% +$14.6K 0.37% 83
2016
Q3 		$455K Sell
5,755
-1,632
-22% -$133K 0.47% 59
2016
Q2 		$614K Buy
7,387
+2,581
+54% +$229K 0.56% 49
2016
Q1 		$442K Buy
4,806
+406
+9% +$36.6K 0.44% 68
2015
Q4 		$445K Buy
+4,400
New +$458K 0.44% 62

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Girard Securities's GILD Position: Q3 2017 in Review

Girard Securities sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 5,025 shares — an estimated $356K sold.

Girard Securities first reported a position in GILD in Q4 2015 and held it in 7 quarters. The position peaked at $614K in Q2 2016. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Girard Securities reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Girard Securities sold 5,025 Gilead Sciences shares in Q3 2017, an estimated $356K.
  • Girard Securities first reported a position in Gilead Sciences in Q4 2015 and held it in 7 quarters.
  • Girard Securities's Gilead Sciences position peaked at $614K in Q2 2016.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Girard Securities's 13F filing for Q3 2017, filed 14 Nov 2017.